Furthermore, the Annexin V assay show that the percentage of apoptotic cells in FAM46A-overexpression ovarian cancer cells treated with CDDP was much lower compared than that in control cells (Figure 2(d)). This evidence concerns the gene ANXA5 and ovarian cancer.